For years, MASH was where drug development dreams went to die.  | After Rezdiffra’s approval and Wegovy’s label expansion, ...

Another NBA season is upon us, which means it's time for an annual rite of passage unlike any other: Finding out why Your ...

Land Rover's second-generation Discovery, a.k.a. the Series II, reminds us of a slightly pudgy kid who shows up for a track ...

I knew college meant going to school. Yet it seemed I forgotten that through the whirlwind that was welcome week, moving in, ...

The star-studded 2025 recruiting class will have its fingerprints all over the upcoming college basketball season ...

Don't let a shaky economy and volatile market derail your retirement. These moves will help ensure your money lasts as long as you do.

California’s school funding system, overhauled in 2013 to make it more equitable, is contributing to more inequality, a situation felt most sharply in counties that have a combination of rich and ...

(Reuters) -Pfizer (PFE) said on Monday it would acquire drug developer Metsera (MTSR) in a deal valued at up to $7.3 billion, including future payments, as it seeks to gain a foothold in the ...

Metsera brings its portfolio of experimental obesity drugs, with MET-097i, a GLP-1 injectable, and MET-233i, which mimics the pancreatic hormone amylin, being the key among them. MET-233i is being ...

Kali Linux has released version 2025.3, the third version of 2025, featuring ten new tools, Nexmon support, and NetHunter improvements. Kali Linux is a distribution created for cybersecurity ...

Investing.com-- Pfizer Inc (NYSE:PFE) is close to launching a $7.3 billion takeover offer for anti-obesity drug maker Metsera Inc (NASDAQ:MTSR), which could be the former’s biggest deal in two years ...